companydata.dkcompanydata.dk

LEKAPHARM A/S: Financial statements 2015

CVR: 32945945

Source: annual report 2015, Danish Business Authority

01/01/2015 – 31/12/2015

LEKAPHARM A/S (CVR 32945945) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK 5,260,469 and a net result of DKK 1,873,272 compared with DKK 1,590,630 the year before. That is an increase of 0.8% compared with the year before. Equity in the 2015 report amounted to DKK 8,748,130. The solvency ratio was 68.5%.

Gross Profit
DKK 5,260,469
Profit/Loss
DKK 1,873,272
Equity
DKK 8,748,130
Total Assets
DKK 12,774,319

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2015-5.3 mio.1.9 mio.8.7 mio.-
2014-5.2 mio.1.6 mio.12.9 mio.-
2013-4.5 mio.1 mio.11.8 mio.-
2012-----

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is LEKAPHARM A/S?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2015

LEKAPHARM A/S: The 2014 annual report is outJun 26, 2015

LEKAPHARM A/S has published its annual report for 2014. Gross profit came to DKK 5,217,509, and the net result was DKK 1,590,630.

About LEKAPHARM A/S

LEKAPHARM A/S is a Danish company of the type Aktieselskab based in Kværndrup, founded in 2010. The company is registered under the industry Engroshandel med andre fødevarer. The management consists of Lasse Kjeldsen. The board consists of Susanne Frederiksen (chair), Emil Bødker Kjeldsen and Lasse Kjeldsen. The company is owned by LKJ HOLDING 2010 ApS, CE-PHARMAMACHINERY ApS and Familien Kjeldsen Holding ApS. The company has 5 employees (2026). In 2025, the company reported a gross profit of DKK 10,369,416 and a net result of DKK 5,517,066 compared with DKK 2,051,529 the year before. Equity in the 2025 report amounted to DKK 7,972,163.

Source: annual report 2025, Danish Business Authority